Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

APG-2449

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Ascentage Pharma

Drug class:

Multi-tyrosine kinase inhibitor, ALK inhibitor, ROS1 inhibitor, FAK inhibitor

Related drugs:

‹

FAK-JAK 2 dual Inhib (0)

dasatinib (215)

sorafenib (180)

anlotinib (139)

sunitinib (139)

lenvatinib (90)

gilteritinib (75)

cabozantinib tablet (74)

regorafenib (65)

midostaurin (51)

repotrectinib (27)

vandetanib (26)

cabozantinib capsule (24)

nintedanib (18)

pexidartinib (6)

sorafenib nanoparticle (0)

crizotinib (312)

entrectinib (178)

alectinib (104)

lorlatinib (94)

brigatinib (50)

ensartinib (42)

iruplinalkib (11)

unecritinib (6)

ALK inhibitor (0)

taletrectinib (5)

FAK-JAK 2 dual Inhib (0)

›

ROS1 positive	Mesothelioma	ROS1 positive	Mesothelioma	APG-2449 Sensitive: C2 – Inclusion Criteria APG-2449 Sensitive : C2	APG-2449 Sensitive: C2 – Inclusion Criteria APG-2449 Sensitive : C2
ALK positive	Mesothelioma	ALK positive	Mesothelioma	APG-2449 Sensitive: C2 – Inclusion Criteria APG-2449 Sensitive : C2	APG-2449 Sensitive: C2 – Inclusion Criteria APG-2449 Sensitive : C2
ROS1 positive	Non Small Cell Lung Cancer	ROS1 positive	Non Small Cell Lung Cancer	APG-2449 Sensitive: C2 – Inclusion Criteria APG-2449 Sensitive : C2	APG-2449 Sensitive: C2 – Inclusion Criteria APG-2449 Sensitive : C2
ALK positive	Non Small Cell Lung Cancer	ALK positive	Non Small Cell Lung Cancer	APG-2449 Sensitive: C2 – Inclusion Criteria APG-2449 Sensitive : C2	APG-2449 Sensitive: C2 – Inclusion Criteria APG-2449 Sensitive : C2